Zhejiang Tianyu Pharmaceutical Co., Ltd.
300702.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.72B
Close$
Share Statistics
| Market cap | $7.72 Billion |
|---|---|
| Enterprise Value | $8.99 Billion |
| Dividend Yield | $0.05 (0.23%) |
| Earnings per Share | $0.41 |
| Beta | 0.25 |
| Outstanding Shares | 345,266,275 |
Return
| Return on Equity | 2.64% |
|---|---|
| Return on Assets | 1.37% |
| Return on Invested Capital | 4.57% |
Valuation & Multiples
| P/E Ratio | 82.15 |
|---|---|
| PEG | -3228.65 |
| Price to Sales | 2.08 |
| Price to Book Ratio | 2.08 |
| Enterprise Value to Revenue | 2.57 |
| Enterprise Value to EBIT | 48.26 |
| Enterprise Value to Net Income | 95 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.54 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Tianyu Pharmaceutical Co., Ltd.
4,686 employees
CEO: Yong Jun Tu Zhejiang Tianyu Pharmaceutical Co., Ltd. is a global enterprise specializing in the entire lifecycle, from the innovation to the commercialization, of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company...